Literature DB >> 27103352

(90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes.

Robert J Lewandowski1, Larry Donahue1, Attasit Chokechanachaisakul2, Laura Kulik3, Samdeep Mouli1, Juan Caicedo2, Michael Abecassis2, Jonathan Fryer2, Riad Salem1, Talia Baker2.   

Abstract

BACKGROUND: The purpose of this study is to assess operative, post-operative, and long-term outcomes in patients who underwent radiation lobectomy (RL) for tumor control and/or hypertrophy of small future liver remnant (FLR) prior to resection.
METHODS: Right lobar +/- segment 4 radioembolization was performed prior to lobectomy/tri-segmentectomy in patients with hepatic tumor but inadequate FLR. Parenchymal/tumor volumes were calculated from pre/post-RL imaging; FLR/%FLR hypertrophy were determined. Complications were graded by the Clavien-Dindo classification.
RESULTS: Thirteen patients (HCC n = 10, cholangiocarcinoma n = 2, mCRC n = 1) underwent RL prior to resection. The median time between RL and post-RL imaging was 40 days (23-190 days); the median time to resection was 86 days (30-210 days). Median FLR increased significantly [pre: 33% (22-43%); post: 43% (29-69%), P < 0.01] to yield a median %FLR hypertrophy of 30% (4-105%). The median hospital stay after resection was 4 days (3-11 days). Transient hepatobiliary toxicities normalized post-operatively. Ninety-two percent of resected tumors had >50% pathologic necrosis. Median follow up time after surgery was 604 days (144-1,416 days); one death occurred.
CONCLUSIONS: In this preliminary study, radiation lobectomy was a safe and effective method to achieve remnant liver hypertrophy while providing tumor control. This approach may facilitate safe resection and favorable post-operative outcomes.J. Surg. Oncol. 2016;114:99-105.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  future liver remnant; hepatectomy; radioembolization; resection; yttrium-90

Mesh:

Substances:

Year:  2016        PMID: 27103352     DOI: 10.1002/jso.24269

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  30 in total

1.  Neoadjuvant transarterial radiation lobectomy for colorectal hepatic metastases: a small cohort analysis on safety, efficacy, and radiopathologic correlation.

Authors:  Jehan L Shah; Ivan R Zendejas-Ruiz; Linday M Thornton; Brian S Geller; Joseph R Grajo; Amy Collinsworth; Thomas J George; Beau Toskich
Journal:  J Gastrointest Oncol       Date:  2017-06

2.  Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.

Authors:  Riad Salem; Siddharth A Padia; Marnix Lam; Jon Bell; Carlo Chiesa; Kirk Fowers; Bonnie Hamilton; Joseph Herman; S Cheenu Kappadath; Thomas Leung; Lorraine Portelance; Daniel Sze; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

Review 3.  Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.

Authors:  Alexander Villalobos; Mohamed M Soliman; Bill S Majdalany; David M Schuster; James Galt; Zachary L Bercu; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 4.  Frontiers of therapy for hepatocellular carcinoma.

Authors:  Michael Heller; Neehar D Parikh; Nicholas Fidelman; Dawn Owen
Journal:  Abdom Radiol (NY)       Date:  2021-04-10

Review 5.  Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.

Authors:  Zersenay Alem; Timothy E Murray; Csilla Egri; John Chung; David Liu; Khaled M Elsayes; Silvia D Chang; Alison Harris
Journal:  Abdom Radiol (NY)       Date:  2021-04-28

Review 6.  Update on Embolization Therapies for Hepatocellular Carcinoma.

Authors:  Sirish Kishore; Tamir Friedman; David C Madoff
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

7.  Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.

Authors:  Ashley L Titan; Kelly Devereaux; John D Louie; George A Poultsides
Journal:  Dig Dis Sci       Date:  2017-11-08       Impact factor: 3.199

8.  Intrahepatic cholangiocarcinoma, are we making progress?

Authors:  Andre Gorgen; Nicolas Goldaracena; Wei Zhang; Gonzalo Sapisochin
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

Review 9.  Modified Radiation Lobectomy: An Evolving Paradigm to Convert Patients to Liver Resection Candidacy.

Authors:  Ahmed Gabr; Ahsun Riaz; Samdeep Mouli; Kush Desai; Bartley Thornburg; Riad Salem; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 10.  Current locoregional therapies and treatment strategies in hepatocellular carcinoma.

Authors:  L Cardarelli-Leite; A Hadjivassiliou; D Klass; J Chung; S G F Ho; H J Lim; P T W Kim; A Mujoomdar; D M Liu
Journal:  Curr Oncol       Date:  2020-11-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.